Am J Transplant, Volume 20, Suppl 3 Archives - Page 15 of 223 - ATC Abstracts

2020 American Transplant Congress
Kidney Paired Donation Outcomes among High PRA Recipients
A. Thomas¹, A. Shaffer², M. Henderson², D. Segev²
¹University of North Carolina, Chapel Hill, NC, ²Johns Hopkins, Baltimore, MD
*Purpose: Kidney paired donation (KPD) accounts for an increasing amount of living donor transplants in the US. Previous studies have shown equivalent outcomes between transplants…
2020 American Transplant Congress
What Are the Peri-Operative and Longterm Outcomes of Utilizing Donation after Circulatory Death Livers with Macrosteatosis? A Multicenter Analysis
K. Croome¹, A. Mathur², S. Mao¹, B. Aqel³, P. Senada¹, J. Piatt¹, J. Heimbach⁴, A. Moss³, C. Rosen⁴, C. Taner¹
¹Mayo Clinic Jacksonville, Jacksonville, FL, ²Mayo Clinic Arizona, Scotsdale, AZ, ³Mayo Clinic Arizona, Scottsdale, AZ, ⁴Mayo Clinic Rochester, Rochester, MN
*Purpose: Given the potentially additive risk from using donor livers that are both steatotic and from a donation after circulatory death(DCD) donor, there is a…
2020 American Transplant Congress
Can Biliary Internal Stents Reduce Biliary Complications in Adult Liver Transplantation?
Y. Kwon¹, Y. S. Genyk¹, Y. Yoon²
¹Division of Hepatobiliary, Pancreas, and Abdominal Organ Transplant, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, ²Division of Hepatobiliary, Pancreas, and Abdominal Organ Transplant, Department of Surgery, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, Republic of
*Purpose: Biliary complications remain a consistent cause of morbidity and mortality in liver transplant (LT) recipients and there is controversy as to whether the use…
2020 American Transplant Congress
Multiplicity of Non-HLA Targets for Antibodies Developed in Association with Ventricular Assist Device Implantation
M. Askar, D. Bhakta, H. Zafar, A. Alam, L. Pittmon, S. Kang, L. Klingman, J. Felius, S. M. Joseph, D. Wencker, D. M. Meyer, S. A. Hall
Baylor University Medical Center and Baylor Scott & White Research Institute, Dallas, TX
*Purpose: Multiple non-HLA antibodies have been implicated in poor outcomes after heart transplantation. Development of HLA and Non-HLA antibodies have been reported in association with…
2020 American Transplant Congress
Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease after Kidney Transplantation
M. Raynaud¹, O. Aubert¹, P. Reese², M. Naesens³, D. Glotz¹, C. Legendre¹, S. Jordan⁴, M. Stegall⁵, D. Segev⁶, C. Lefaucheur¹, A. Loupy, On behalf of the study NCT03474003¹
¹Paris Transplant Group, Paris, France, ²University of Pennsylvania, Philadelphia, PA, ³Department of Transplantation, Leuven, Belgium, ⁴Cedars Sinai, Los Angeles, CA, ⁵Mayo Clinic, Rochester, MN, ⁶Johns Hopkins, Baltimore, MD
*Purpose: Although the current gold standard of monitoring kidney transplant function relies on glomerular filtration rate (GFR) assessment, little is known about GFR trajectories after…
2020 American Transplant Congress
A Simple HLA Class II Matching Strategy for the Prediction of De Novo Donor-Specific HLA Antibodies
L. G. Hidalgo¹, I. A. Martinez Juarez², L. Morales-Buenrostro³, S. Shojai⁴, P. Campbell⁴
¹Surgery, University of Wisconsin - Madison, Madison, WI, ²Nephrology, Hospital Angeles Pedregal, Mexico City, Mexico, ³Nephrology, Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico, ⁴Medicine, University of Alberta, Edmonton, AB, Canada
*Purpose: In kidney transplantation, degree of HLA Class II mismatch (MM) between donor and recipient drives the risk to develop de novo DSA (dnDSA). New…
2020 American Transplant Congress
Safety and Effectiveness of Early Initiation of SGLT2 Inhibitors in Diabetic Kidney Transplant Recipients
C. Song¹, R. Winstead¹, A. Brown¹, M. Demehin¹, I. Yakubu¹, I. Moinuddin², G. Gupta²
¹Pharmacy, Virginia Commonwealth University Health, Richmond, VA, ²Virginia Commonwealth University Health, Richmond, VA
*Purpose: Metabolic complications such as post-transplant diabetes (PTDM) are quickly becoming the leading causes of death in kidney transplant (KT) recipients. The use of Sodium…
2020 American Transplant Congress
Pumping in Pediatric Kidney Transplantation—Does it Matter?
M. MacConmara, J. Gattineni, D. Desai, P. Vagefi, C. S. Hwang
UT Southwestern, Dallas, TX
*Purpose: Pulsatile perfusion of deceased donor kidneys is commonly practiced in adult kidney transplantation. We examined the practice of pulsatile perfusion in pediatric patients undergoing…
2020 American Transplant Congress
De Novo NAFLD Post-Liver Transplant is Defined by Altered Lipid Metabolism and Mitochondrial Dysfunction
M. Bhat¹, E. Pasini¹, M. Angeli¹, J. Allard², A. Humar¹
¹Multi-Organ Transplant, UHN, Toronto, ON, Canada, ²Division of Gastroenterology and Hepatology, UHN, Toronto, ON, Canada
*Purpose: De Novo Non-alcoholic Fatty Liver Disease (NAFLD) affects up to 35% of liver transplant (LT) recipients transplanted for non-NAFLD indications. Non-alcoholic steatohepatitis (NASH), the…
2020 American Transplant Congress
Outcomes of Kidney Transplant Patients Evaluated, Listed and Managed Using A Distant Transplant Outreach Care Model (DTrOM)
M. Mujtaba, M. Kueht, S. Hussain, A. Rizvi, S. Shah, R. Kulkarni, S. N. Merwat, A. Gamilla-Crudo, K. Gugliuzza, J. Fair
UTMB, Galveston, TX
*Purpose: All advanced kidney disease and post-transplant patients are not always fortunate enough to be living close to a transplant care center. To this end,…